chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Aprox after 11 hours, developed increased temperature in 99'F range (my normal temp is around 97.7'F).  Aprox 24 hours through 36 hours, temperature fluctuated between 99.3'F and 101.2'F.  Arm was sore and would have a burning sensation in the first few hours.  Continued to be sore and hand/fingers felt numb or hurt up to apox 72-80 hours after.  Had a serious migraine through out staring aprox 24 hours after vaccine, which was worse than normal.  Felt ill/light headed due to increased temperature probably.
Developed shingles in right eye overnight - lost sight for several days. Eye painful and totally red. Treatment: Prednisone, famiciclovir, and triflunidine.
The pt experienced an injection site reaction which was hard and hot to touch with redness and pain. No fever was reported. The pt was treated with cool pack, Benadryl, Tylenol.
Faint, dizziness, trouble breathing, nauseous, headaches, weird feelings in head like heightened nerve sensations
About 5 minutes after receiving the shot, the patient began to feel "weird" and had a "chemical" taste in the back of her throat. She sat back down and then said that her heart felt like it was racing. I told her that I was going to get the nurse. I then informed RN of the situation. She said she still felt her heart was racing and that her chest felt heavy when nurse asked her about her symptoms. She then said she hadn't eaten all day hardly so she took a bar out of her purse and ate that to see if it would help. Her symptoms improved a little bit. However, a couple of minutes later, she said that her arms felt like they had pins pricking them. Medical Assistant took the patient's blood pressure in which it was slightly elevated. RN continued to monitor her symptoms. After 30 minutes of monitoring had passed and no resolution of symptoms, we told the patient that we were going to call an ambulance. The patient agreed. EMS promptly arrived 5 minutes later and took the patient into a room. After assessment, they decided it was best to take the patient to the Emergency Room.
A 21 year old male received Havrix #1, IM at job site. c/o feeling lightheaded after vaccine administered. Color became pale and began perspiring. Seated with head between knees and cold compress to neck. A few minutes later sat up. Color better. Approximately 11:40am while still seated appeared to experience seizure. Body convulsed. Eyes rolled back. Not responsive to stimuli. Diaphoretic. EMS called 11:40 AM BP 88/64 P62 prior to seizure, 11:45am approximately appeared to experienced seizure as described, 11:46am approximately BP 102/70 P80 now responding to his name. Alert. "Fells like had a dream! Oriented to date and place. EMS arrived and took VS. Patient alert, but dazed 1205 pm Transported by EMS to hospital accompanied by co-worker for follow up evaluation. Ambulated to transport vehicle without problems.
11/14/06 Influenza vaccine.  11/15/06 Arm reddened and swollen, temperature 103.  11/16/06 Arm increased swelling and redness, clusters of blisters around injection site.
Dose was given after expiration date. Expiration date was 07/13/2022. Dose was administered on 08/04/2022.
Patient broke out with what seem to be insect bites all over her legs on Saturday morning. After about 30 minutes the insect bites were all over her arms, back, stomach and legs. After allergy medicine to stop the itching, the bumps went away for approx. 4 hours and then it began all over again the next morning. This is the third continuous day of this routine.
Red arm  warm to touch  Itch.  Took Benedryl  Ice on arm area where redness was .
The following morning after receiving the vaccine I was bed ridden, terrible allodynia, nausea, chills and body aches. These symptoms lasted for ten days. The allodynia was the most horrific symptom. I had these same symptoms for the first dose. I started not feeling well on 01/01/2023 with a slight cough and progressed from there. I tested for COVID-19 on 01/02/2023 and 01/03/2023 with two different manufacturers and they were negative. On 01/04/2023 I tested positive for COVID-19 with a home test. I tested again on 01/05/2023 with another manufacturer home test and it was positive. I had stuffy head; a wet cough and I lost my sense of taste and smell. I was not eligible for the prescription for PAXLOVID since I was outside the window. As of today, I have improved but I still having symptoms.
Received a vaccine which was more than 12 days in the refrigerator; Received a vaccine which was more than 12 days in the refrigerator; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Aug-2021 and was forwarded to Moderna on 13-Aug-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 12 days in the refrigerator) and PRODUCT STORAGE ERROR (Received a vaccine which was more than 12 days in the refrigerator) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 12 days in the refrigerator) and PRODUCT STORAGE ERROR (Received a vaccine which was more than 12 days in the refrigerator). On 15-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Received a vaccine which was more than 12 days in the refrigerator) and PRODUCT STORAGE ERROR (Received a vaccine which was more than 12 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Pt recvd 3 doses of Engerix-B & it was determined that pt did not seroconvert;
sore arm; first dose of Pfizer-Biontech Covid19 vaccine on 24Feb2021, and contracted Covid19 on 02Mar2021.; This is a spontaneous reported from a contactable female consumer (patient herself) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an un-specified route of administration on 24Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization.The patient's historic vaccine included Shingrix, which "almost killed me" and when completing the Shingrix series stated the "second one was horrible and The concomitant medications were not reported. The patient received her first dose of Pfizer-Biontech Covid19 vaccine on 24Feb2021, and contracted Covid19 on 02Mar2021. She mentioned she was pleasantly surprised to have just a sore arm. she was glad it was nothing like her experience with Shingrix. She wants to know if she can get her next dose on 17Mar2021 as scheduled. She wants to know if she needs to restart the series, after she gets well. The outcome of the events was un-known. Information on the lot/batch number has been requested.
Initial report received from a healthcare professional on 12 August 2013. A 30-year-old female patient had received an intramuscular dose 1 of ADACEL vaccine (batch number: U4313AA and site of administration was not reported) on 12 August 2013. The patient was pregnant at the time of vaccination. The patient's last menstrual period date was 12 January 2013. The estimated date of delivery was 19 October 2013. Patient's health during pregnancy, risk factors, concomitant medications and medical history were not reported. Treatment for infertility was not reported. Laboratory details were not reported. At the time of the report, the patient had not experienced any adverse event. Documents held by sender: none.
Headache, extreme fatigue, bright flush but no fever, body aches, muscle tiredness, knot at injection site
Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 18Mar2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and did not take any concomitant medication. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced tinnitus. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as the result of reported event tinnitus. The clinical outcome of the event tinnitus was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and referring to a patient (pt) of unknown gender, whose age at the time of vaccination with zoster vaccine live (ZOSTAVAX) was at least 68 years old. The pt's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unspecified date in 2015, the pt was administered zoster vaccine live (ZOSTAVAX) vaccine (lot#, expiration date, dosage, route of administration and anatomical location were not provided) for the long-term prevention of shingles and zoster-related conditions, by a pharmacist at a pharmacy. Subsequently, on an unknown date, the pt was treated by a healthcare provider at a medical center for the following injuries resulting from the pt's use of zoster vaccine live (ZOSTAVAX): herpes zoster. The outcome of herpes zoster was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Rt arm mild swelling and tenderness in the deltoid area. Patient took Ibuprofen and it helped. 1/4 inch lesion on right arm.
Raised and reddened are approximately 1.5"x 3" in size at the site of injection. Tender, itchy, and has deep tissue tenderness.
I broke out in hives all over my body.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (unknown if pregnant) received BNT162b2 (BNT162B2), on 03Aug2021 as dose 2, single (Batch/Lot number: unknown) at the age of 39 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Anti inflammatories, reaction(s): "Known allergies: Anti inflammatories". Vaccination history included: Bnt162b2 (DOSE: 1, Batch/Lot No: Unknown. Misplaced/discarded), for COVID-19 immunization. The following information was reported: URTICARIA (non-serious), outcome "recovered with sequelae", described as "I broke out in hives all over my body.". The event "i broke out in hives all over my body." required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of urticaria.  Additional Information: Patient was not having COVID prior vaccination and patient was tested with Covid post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever, extreme headache, vomiting, body aches, light sensitivity, chest pain, extreme fatigue, arm pain at the site of injection.
Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days; administered moderna vaccines beyond the use date and/or expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired) and PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired) and PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the Reporter.  It was mentioned in the report that the vaccines to be stored with 1 to 3 bottles in the fridge to thawout and to be ready for the patients when needed and at worst scenarios vaccines would have been in the fridge for about a week if no one came in to be vaccinated      No Treatment Medications were provided by the Reporter.
Terrible pain in right bicep and shoulder. It is ongoing since the day after my booster shot. It  is also VERY painful to lift my arm to chest level much more when trying to get something off a shelf. I am not happy that the news lied to me that there were no complications. I NEVER have pain in the shoulder/arm/bicep before now.
Vaccine mixed with incorrect diluent (sterile water instead of normal saline). Pt informed of error and offered revaccination. Pt reports sore arm with onset about 5 days after vaccination that lasted about 15 days.
Information has been received from a physician concerning a 23 year old female patient who on 01-MAR-2007 was vaccinated in right deltoid with a first dose of GARDASIL vaccine, lot #656372/0243U. The patient became dizzy after receiving the injection. She also had stomach cramps when she got home (severe). Weakness and the start of menses shortly after the vaccination. Unspecified medical attention was sought. The patient's outcome was unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 4/6/2007. The patient recovered from stomach cramps and weakness on 01-MAR-2007. The outcome of dizziness was unknown. Additional information is not expected.
Reactive arthritis, starting with acute monoarticular arthritis of the right knee, then progressing to a migratory polyarthritis, with involvement of both knees, both wrists, both thumbs, jaw, and PIP joints of the left hand
The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 11-Aug-2022; No adverse event; Administered Moderna COVID-19 Vaccine after 30-day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 11-Aug-2022) and NO ADVERSE EVENT (No adverse event) in an 18-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 11-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 11-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 11-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 11-Aug-2022).    No concomitant medications were reported.   The vial did not undergo any temperature excursions.  No treatment details were reported.
twitching movement belowher right eye; Sharp pain belowher right eye; stiffness at the injection site; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (twitching movement belowher right eye), EYE PAIN (Sharp pain belowher right eye), MUSCULOSKELETAL STIFFNESS (stiffness at the injection site) and VACCINATION SITE PAIN (pain at the injection site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021 at 12:00 PM, the patient experienced MUSCLE TWITCHING (twitching movement belowher right eye), EYE PAIN (Sharp pain belowher right eye), MUSCULOSKELETAL STIFFNESS (stiffness at the injection site) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, MUSCLE TWITCHING (twitching movement belowher right eye) and EYE PAIN (Sharp pain belowher right eye) had not resolved and MUSCULOSKELETAL STIFFNESS (stiffness at the injection site) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Non-significant follow-up: Reporter contact information updated
at 7:30 to 8pm she started experiencing headache and chills. 2am Pt started feeling nauseous, diarrhea. She ended up passing out and throwing up. She hit her head when she passed out and reports her hip is hurt. I advised her to go to urgent care and get head/hip checked out.
Sore arm; Painful to move; dose number=3; This is a spontaneous report from a non-contactable reporter (consumer or other non-HCP).   A 13-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 16Jan2022 at 14:15 (Lot number: FJ6369) at the age of 13 year(s) as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Lactose intolerance" (unspecified if ongoing). The patient did not receive any concomitant medications. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Lot number: EW0185, Anatomical site: Arm left, Route of administration: Intramuscular.), administration date: 06Jun2021, when the patient was 12 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 1, SINGLE, Lot number: EW0185, Anatomical site: Arm left, Route of administration: Intramuscular.), administration date: 16May2021, when the patient was 12 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 16Jan2022 at 14:15, outcome "unknown", described as "dose number=3"; PAIN IN EXTREMITY (non-serious) with onset 16Jan2022 at 16:00, outcome "recovering", described as "Sore arm"; PAIN (non-serious) with onset 16Jan2022 at 16:00, outcome "recovering", described as "Painful to move". Therapeutic measures were taken as a result of pain in extremity and pain.  Additional information: The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Treatment for the reported events included Tylenol and cold compresses.   No follow-up attempts are possible. No further information is expected.
Adverse events-DTaP-HepB-IPV (PEDIARIX) HIB PREVNAR 13 ROTARIX given 5/17/16 and again on  6/1/16.
This spontaneous report was received from an unspecified reporter via a company representative concerning a patient of unknown age and gender. On an unknown date, the patient was vaccinated with an expired dose of M-M-R II (lot number unspecified, expiry date was reported as March 2013, dose and route unspecified). No concomitant therapy was reported. Additional information has been requested.
Erythema, heat and swelling at injection site 7 days after injection. Axillary lymph node lymphadenopathy 6 days after injection.
Administration of vaccine past published expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of vaccine past published expiry) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of vaccine past published expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of vaccine past published expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Number of doses/vials: 19 doses HCP stated that the first dose details were not asked. The vial was initially stored in the refrigerator on 01-Apr-2022 and thawed on the day of use. The vaccine were thawed on the day of administration and administration was spread out throughout the end of March to the beginning of April. 19 patients were administered on 29-Mar-2022, 30-Mar-2022, 31-Mar-2022, 01-Apr-2022 and 04-Apr-2022. The vial did not undergo any temperature excursions. No treatment information was reported.
I went for a normal check up. My blood pressure was up. My blood pressure is been up for about a month now.
Pt. states she awoke at 5 am with head to toe hives. No throat or respiratory system problems. She called her physician and he told her to take BENADRYL. She also stated she had a "bad" headache, unrelieved with her normal treatment.
Ear Infection, Augmentin, cleared up in 2 days and finished course of antibiotics
pt vaxed 21MAY93 w/in 24 hrs devel erythema, induration, warmth & tenderness @ inject site-worsened & seen by MD on 26MAY; react now from site to elbow-itching, warm erythematous & swollen dx: cellulitis, hospitalized-high risk pt; tx w/ATB